查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1726345

血液過濾和淨化市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測，2025 年至 2030 年

Blood Filtration And Purification Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 125 Pages | 商品交期: 2-10個工作天內

價格

血液濾過和淨化市場的成長和趨勢

根據Grand View Research, Inc.的最新報告，全球血液過濾和淨化市場規模預計到2030年將達到56.3億美元，2025年至2030年期間的複合年成長率為7.34%。

血源性疾病盛行率的上升、老年人口的成長以及對血液淨化療法的認知的提高等關鍵促進因素正在推動市場成長。

由於嚴重患者迫切需要有效的治療方案，臨床診斷血液過濾和淨化產業在新冠疫情期間經歷了大幅成長。在此期間，最重要的工具是先進的血液淨化套件，它在控制嚴重的發炎反應、器官衰竭和與病毒相關的併發症發揮了關鍵作用。

處於這一創新前沿的是OXIRIS，這是一種多功能血液淨化過濾器組，也是美國唯一能夠從血液中去除細胞激素和發炎介質，同時也能提供持續腎臟替代療法（CRRT）的產品。在疫情期間，OXIRIS已成為治療患有細胞激素風暴、敗血症和急性腎損傷的嚴重COVID-19患者的關鍵治療方案。透過有效去除發炎物質，該套件有助於穩定患者病情、減輕加護治療負擔並改善生存結果。

Thermo Scientific 的 GeneJET 全血基因組 DNA 純化迷你試劑套件因其快速、基於旋轉管柱的矽膠膜技術而脫穎而出。該套件簡化了從全血中提取 DNA 的過程，無需進行危險的苯酚-氯仿提取和耗時的酒精沉澱。標準方案需要不到 20 分鐘的裂解後時間，並產生高分子量 DNA（>30 kb），適用於 PCR、Southern 印跡和酶促測定等下游應用。該套件的簡單性和可靠性使其成為尋求快速安全地擴大基因組診斷規模的實驗室的理想選擇。

SpiNXT 血液 DNA 萃取試劑盒是另一種創新解決方案，專為全血、血漿、血清、淋巴細胞和白血球層使用而設計。二氧化矽結合化學和微型旋轉管柱形式的結合可以從多種血液樣本類型中分離出高產量、高純度的 DNA。 SpiNXT套件無需有機溶劑或複雜儀器，可快速處理並相容於多種臨床基因檢測。

另一方面，sbeadex 血液 DNA 純化試劑盒專注於以微珠為基礎的技術。該試劑套件專為高達 200 μL 的樣品量而設計，支援高性能自動化工作流程，並與 Thermo Fisher 的 KingFisher™ 系統等流行平台完全相容。水性清洗緩衝液可消除有機溶劑和 PCR 抑制劑的殘留，確保潔淨的 DNA 適用於 qPCR、NGS、桑格定序和遺傳疾病篩檢等敏感應用。

此次疫情凸顯了血液淨化套件在管理高風險患者中的重要角色。隨著醫療保健系統適應 COVID-19 的挑戰，這些套件不僅已成為輔助診斷而且也用於治療性介入的重要工具。其影響超越了疫情本身，並繼續用於治療敗血症、腎臟損傷和其他發炎引起的疾病。

COVID-19 危機加速了血液過濾和淨化套件（例如 OXIRIS、CytoSorb、AMBER 和 Hemoclear）的採用，為綜合臨床診斷和重症加護樹立了新的標準。這些創新仍然是現代 ICU 實踐的核心，確保大流行期間獲得的經驗教訓轉化為未來更強大、應對力的醫療保健系統。

血液濾過和淨化市場報告重點

  • 2024 年，過濾套件和試劑部分將佔據市場主導地位，收入佔有率最大，為 35.97%。該領域在確保輸血、醫療和醫學研究的安全性和有效性方面發揮著至關重要的作用，預計將迅速擴張。關鍵促進因素是過濾材料技術的進步和全球對高品質血液製品的需求不斷成長，進一步增強了過濾套件和試劑市場的主導地位。
  • 根據應用，感染疾病診斷領域在 2024 年佔據了最大的市場收益佔有率。這是由於全球感染疾病疫情日益嚴重，以及對準確、快速診斷的迫切需求。由於對精準和個人化醫療保健解決方案的需求不斷成長，預計預測期內基因/分子診斷領域將以最快的複合年成長率成長。
  • 根據最終用途，臨床診斷實驗室部門在 2024 年佔據了最大的市場收益佔有率。這是因為它在疾病檢測和監測中發揮著至關重要的作用。這些實驗室依靠先進的過濾技術來獲取高品質、無污染的血液樣本，以進行準確的檢測，特別是在感染疾病診斷、基因檢測和腫瘤學方面。隨著個人化醫療和疾病早期檢測的興起，臨床診斷實驗室正在採用尖端過濾技術，推動這一細分市場的規模和成長。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章血液過濾和淨化市場變​​數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 血液過濾和淨化市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析

第4章血液過濾和淨化市場：按產品分類的估計和趨勢分析

  • 血液濾過和淨化市場：產品儀表板
  • 全球血液濾過和淨化市場的產品趨勢分析
  • 全球血液濾過與淨化市場：產品展望
  • 過濾試劑套件和試劑
  • 薄膜、過濾器和耗材
  • 樣品製備系統
  • 專用分析試劑與管柱

第5章血液過濾和淨化市場：按應用進行的估計和趨勢分析

  • 血液濾過和淨化市場：應用儀表板
  • 全球血液過濾與淨化市場應用變化分析
  • 全球血液濾過與淨化市場：應用展望
  • 感染疾病診斷
  • 毒理學和免疫診斷學
  • 癌症診斷
  • 基因/分子診斷
  • 其他（代謝、罕見疾病小組）

第6章。血液過濾和淨化市場：按最終用途的估計和趨勢分析

  • 血液濾過和淨化市場：最終用途儀表板
  • 全球血液濾過和淨化市場最終用途趨勢分析
  • 全球血液濾過和淨化市場：依最終用途分類的展望
  • 臨床診斷
  • 醫院
  • 研究和學術機構
  • 其他

第7章。血液過濾和淨化市場：按產品、應用、最終用途和地區進行的估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 主要經銷商和通路合作夥伴名單
    • 2024年主要企業市場佔有率分析
    • Thermo Fischer Scientific
    • MilliporeSigma
    • Roche Lifescience
    • Sigma Aldrich
    • Avantor.
    • Takara Bio
    • MP Biomedicals
    • QIAGEN NV
    • HiMedia
    • BIoTage
Product Code: GVR-4-68040-560-0

Blood Filtration And Purification Market Growth & Trends:

The global blood filtration and purification market size is anticipated to reach USD 5.63 billion by 2030 and is projected to grow at a CAGR of 7.34% from 2025 to 2030, according to a new report by Grand View Research, Inc. Key driving factors such as increasing prevalence of blood-borne diseases, growing geriatric population, rising awareness of blood purification therapies have fueled the market growth.

The blood filtration & purification industry in clinical diagnostics experienced a major surge during the COVID-19 pandemic, driven by the urgent need for effective treatment solutions for critically ill patients. Among the most vital tools during this period were advanced blood purification kits, which played a critical role in managing severe inflammatory responses, organ failure, and complications associated with the virus.

At the forefront of this innovation was OXIRIS, a multifunctional blood purification filter set-the only one available in the U.S. capable of performing Continuous Renal Replacement Therapy (CRRT) while simultaneously removing cytokines and inflammatory mediators from the blood. During the height of the pandemic, OXIRIS became a key therapeutic solution for managing critically ill COVID-19 patients who were experiencing cytokine storms, sepsis, and acute kidney injury. By efficiently removing inflammatory substances, the kit helped stabilize patients, reduce intensive care burden, and improve survival outcomes.

Thermo Scientific's GeneJET Whole Blood Genomic DNA Purification Mini Kit stands out for its rapid, spin-column-based silica membrane technology. This kit streamlines DNA extraction from whole blood, eliminating the need for hazardous phenol-chloroform extraction or time-consuming alcohol precipitation. With a standard protocol that takes under 20 minutes post-lysis, it delivers high molecular weight DNA (>30 kb), ready for downstream applications like PCR, Southern blotting, and enzymatic assays. The kit's simplicity and reliability make it a preferred choice for laboratories looking to scale genomic diagnostics with speed and safety.

SpiNXT Blood DNA Extraction Kit is another innovative solution, designed for use with whole blood, plasma, serum, lymphocytes, and buffy coat. Combining silica-binding chemistry with a mini spin-column format, it ensures high-yield, high-purity DNA isolations across a range of blood-derived sample types. With no need for organic solvents or complicated equipment, the SpiNXT kit enables fast processing and compatibility with a wide array of clinical genetic assays.

Meanwhile, the sbeadex Blood DNA Purification Kit brings magnetic bead-based technology into focus. Designed for sample volumes up to 200 µL, the kit supports high-throughput automation workflows and is fully compatible with popular platforms like Thermo Fisher's KingFisher(TM) system. Its water-based wash buffers help eliminate carryover of organic solvents and PCR inhibitors, ensuring clean DNA suitable for sensitive applications such as qPCR, NGS, Sanger sequencing, and genetic disorder screening.

The pandemic highlighted the critical role of blood purification kits in managing high-risk patients. As healthcare systems adapted to the challenges of COVID-19, these kits became indispensable tools not only for diagnostic support but also for therapeutic intervention. Their impact has extended beyond the pandemic, with continued use in managing sepsis, kidney injury, and other inflammation-driven conditions.

The COVID-19 crisis accelerated the adoption of blood filtration and purification kits such as OXIRIS, CytoSorb, AMBER, and Hemoclear, setting a new benchmark for integrated clinical diagnostics and critical care. These innovations remain central to modern ICU practice, ensuring that the lessons learned during the pandemic translate into stronger, more responsive healthcare systems going forward.

Blood Filtration And Purification Market Report Highlights:

  • The filtration kits & reagents segment led the market with the largest revenue share of 35.97% in 2024. This segment is expected to see rapid expansion due to its critical role in ensuring the safety and efficacy of blood transfusions, therapeutic treatments, and medical research. A key driving factor is the technological advancements in filtration materials, and a growing global demand for high-quality blood products further contributes to the dominance of filtration kits and reagents in the market.
  • Based on application, the infectious disease diagnostics segment accounted for the largest market revenue share in 2024, due to the growing global prevalence of infectious diseases and the critical need for accurate, rapid diagnostics. The genetic/molecular diagnostics segment is expected to grow at the fastest CAGR over the forecast period, due to the increasing demand for precise, personalized healthcare solutions.
  • Based on end use, the clinical diagnostics laboratories segment accounted for the largest market revenue share in 2024, due to their essential role in disease detection and monitoring. These laboratories rely on advanced filtration technologies to obtain high-quality, contaminant-free blood samples for accurate testing, especially in infectious disease diagnostics, genetic testing, and oncology. With the rise of personalized medicine and early disease detection, clinical diagnostic labs are adopting cutting-edge filtration technologies, driving both the size and growth of this market segment.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Blood Filtration & Purification Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD)
      • 3.2.1.2. Increasing prevalence of bloodborne diseases
      • 3.2.1.3. Advancements in hemodialysis and renal care
      • 3.2.1.4. Rising Demand for safe blood transfusions
      • 3.2.1.5. Technological advancements in filtration and purification systems
      • 3.2.1.6. Growing use of liquid biopsy for cancer diagnostics
      • 3.2.1.7. Regulatory push for improved blood safety standards
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High equipment costs
      • 3.2.2.2. Lack of awareness and skilled professionals
  • 3.3. Blood Filtration & Purification Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Blood Filtration & Purification Market: Product Estimates & Trend Analysis

  • 4.1. Blood Filtration & Purification Market: Product Dashboard
  • 4.2. Global Blood Filtration & Purification Market Product Movement Analysis
  • 4.3. Global Blood Filtration & Purification Market by Product Outlook
  • 4.4. Filtration kits and Reagents
    • 4.4.1. Filtration kits and Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Membranes, Filters and Consumables
    • 4.5.1. Membranes, Filters and Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Sample preparation systems
    • 4.6.1. Sample preparation systems market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Specialty assays and columns
    • 4.7.1. Specialty assays and columns market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Blood Filtration & Purification Market: Application Estimates & Trend Analysis

  • 5.1. Blood Filtration & Purification Market: Application Dashboard
  • 5.2. Global Blood Filtration & Purification Market Application Movement Analysis
  • 5.3. Global Blood Filtration & Purification Market by Application Outlook
  • 5.4. Infectious Disease Diagnostics
    • 5.4.1. Infectious Disease Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Toxicology and Immunodiagnostics
    • 5.5.1. Toxicology and Immunodiagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Cancer Diagnostics
    • 5.6.1. Cancer Diagnostics market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.7. Genetic/Molecular Diagnostics
    • 5.7.1. Genetic/Molecular Diagnostics market estimates and forecasts, 2018 to 2030, (USD Million)
  • 5.8. Others (Metabolic, Rare Disease Panels
    • 5.8.1. Genetic/Molecular Diagnostics market estimates and forecasts, 2018 to 2030, (USD Million)

Chapter 6. Blood Filtration & Purification Market: End-use Estimates & Trend Analysis

  • 6.1. Blood Filtration & Purification Market: End-use Dashboard
  • 6.2. Global Blood Filtration & Purification Market End-use Movement Analysis
  • 6.3. Global Blood Filtration & Purification Market by End-use Outlook
  • 6.4. Clinical Diagnostics
    • 6.4.1. Clinical Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Hospitals
    • 6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Research and Academic Institutes
    • 6.6.1. Research and Academic Institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Blood Filtration & Purification Market: Regional Estimates & Trend Analysis by Product, Application and End-use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. Thermo Fischer Scientific
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. MilliporeSigma
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Roche Lifescience
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Sigma Aldrich
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Avantor.
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Takara Bio
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. MP Biomedicals
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. QIAGEN N.V
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. HiMedia
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Biotage
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table. 1. List of abbreviation
  • Table. 2. North America blood filtration & purification market, by region, 2018 - 2030 (USD Million)
  • Table. 3. North America blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 4. North America blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 5. North America blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 6. U.S. blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 7. U.S. blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 8. U.S. blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 9. Canada blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 10. Canada blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 11. Canada blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 12. Mexico blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 13. Mexico blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 14. Mexico blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 15. Europe blood filtration & purification market, by region, 2018 - 2030 (USD Million)
  • Table. 16. Europe blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 17. Europe blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 18. Europe blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 19. Germany blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 20. Germany blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 21. Germany blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 22. UK blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 23. UK blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 24. UK blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 25. France blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 26. France blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 27. France blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 28. Italy blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 29. Italy blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 30. Italy blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 31. Spain blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 32. Spain blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 33. Spain blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 34. Denmark blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 35. Denmark blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 36. Denmark blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 37. Sweden blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 38. Sweden blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 39. Sweden blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 40. Norway blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 41. Norway blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 42. Norway blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 43. Asia Pacific blood filtration & purification market, by region, 2018 - 2030 (USD Million)
  • Table. 44. Asia Pacific blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 45. Asia Pacific blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 46. Asia Pacific blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 47. China blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 48. China blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 49. China blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 50. Japan blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 51. Japan blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 52. Japan blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 53. India blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 54. India blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 55. India blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 56. South Korea blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 57. South Korea blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 58. South Korea blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 59. Australia blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 60. Australia blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 61. Australia blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 62. Thailand blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 63. Thailand blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 64. Thailand blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 65. Latin America blood filtration & purification market, by region, 2018 - 2030 (USD Million)
  • Table. 66. Latin America blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 67. Latin America blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 68. Latin America blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 69. Brazil blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 70. Brazil blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 71. Brazil blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 72. Mexico blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 73. Argentina blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 74. Argentina blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 75. Argentina blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 76. MEA blood filtration & purification market, by region, 2018 - 2030 (USD Million)
  • Table. 77. MEA blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 78. MEA blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 79. MEA blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 80. South Africa blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 81. South Africa blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 82. South Africa blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 83. Saudi Arabia blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 84. Saudi Arabia blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 85. Saudi Arabia blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 86. UAE blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 87. UAE blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 88. UAE blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)
  • Table. 89. Kuwait blood filtration & purification market, by product, 2018 - 2030 (USD Million)
  • Table. 90. Kuwait blood filtration & purification market, by application, 2018 - 2030 (USD Million)
  • Table. 91. Kuwait blood filtration & purification market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Blood filtration & purification market: market outlook
  • Fig. 14 Blood filtration & purification competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Blood filtration & purification market driver impact
  • Fig. 18 Blood filtration & purification market restraint impact
  • Fig. 19 Blood filtration & purification market: Product movement analysis
  • Fig. 20 Blood filtration & purification market: Product outlook and key takeaways
  • Fig. 21 Filtration kits and reagents estimates and forecast, 2018 - 2030
  • Fig. 22 Membrane, filters and consumables estimates and forecast, 2018 - 2030
  • Fig. 23 Sample Preparation Systems estimates and forecast, 2018 - 2030
  • Fig. 24 Specialty Assays/Columns estimates and forecast, 2018 - 2030
  • Fig. 25 Blood filtration & purification market: Application movement analysis
  • Fig. 26 Blood filtration & purification market: Application outlook and key takeaways
  • Fig. 27 Infectious Disease Diagnostics market estimates and forecast, 2018 - 2030
  • Fig. 28 Toxicology and Immunodiagnostics estimates and forecast, 2018 - 2030
  • Fig. 29 Cancer Diagnostics market estimates and forecast, 2018 - 2030
  • Fig. 30 Genetic/Molecular Diagnostics market estimates and forecast, 2018 - 2030
  • Fig. 31 Others estimates and forecast, 2018 - 2030
  • Fig. 32 Blood filtration & purification market: End-use movement analysis
  • Fig. 33 Blood filtration & purification market: End-use outlook and key takeaways
  • Fig. 34 Clinical Diagnostics market estimates and forecast, 2018 - 2030
  • Fig. 35 Hospitals estimates and forecast, 2018 - 2030
  • Fig. 36 Research and Academic Institutes estimates and forecast, 2018 - 2030
  • Fig. 37 Others market estimates and forecast, 2018 - 2030
  • Fig. 38 Global blood filtration & purification market: Regional movement analysis
  • Fig. 39 Global blood filtration & purification market: Regional outlook and key takeaways
  • Fig. 40 Global blood filtration & purification market share and leading players
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030
  • Fig. 42 US key country dynamics
  • Fig. 43 US market estimates and forecasts, 2018 - 2030
  • Fig. 44 Canada key country dynamics
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 46 Mexico key country dynamics, 2018 - 2030
  • Fig. 47 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 48 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 49 UK key country dynamics
  • Fig. 50 UK market estimates and forecasts, 2018 - 2030
  • Fig. 51 Germany key country dynamics
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 53 France key country dynamics
  • Fig. 54 France market estimates and forecasts, 2018 - 2030
  • Fig. 55 Italy key country dynamics
  • Fig. 56 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 57 Spain key country dynamics
  • Fig. 58 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 59 Denmark key country dynamics
  • Fig. 60 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 61 Sweden key country dynamics
  • Fig. 62 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 63 Norway key country dynamics
  • Fig. 64 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 65 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 66 China key country dynamics
  • Fig. 67 China market estimates and forecasts, 2018 - 2030
  • Fig. 68 Japan key country dynamics
  • Fig. 69 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 70 India key country dynamics
  • Fig. 71 India market estimates and forecasts, 2018 - 2030
  • Fig. 72 Thailand key country dynamics
  • Fig. 73 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 74 South Korea key country dynamics
  • Fig. 75 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 76 Australia key country dynamics
  • Fig. 77 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 78 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 79 Brazil key country dynamics
  • Fig. 80 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 81 Argentina key country dynamics
  • Fig. 82 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 83 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 84 South Africa key country dynamics
  • Fig. 85 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 86 Saudi Arabia key country dynamics
  • Fig. 87 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 88 UAE key country dynamics
  • Fig. 89 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 90 Kuwait key country dynamics
  • Fig. 91 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 92 Market share of key market players - Blood filtration & purification market